SAM
DRNA

Shell Asset Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Shell Asset Management’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,432
Closed -$210K – 1423
2021
Q3 		$210K Sell
10,432
-450
-4% -$9.06K ﹤0.01% 1189
2021
Q2 		$406K Buy
10,882
+590
+6% +$22K 0.01% 1007
2021
Q1 		$263K Buy
+10,292
New +$263K 0.01% 1074